BlossomHill Therapeutics, Inc.

BLSM

BLSMBlossomHill Therapeutics, Inc. US flag

NASDAQ

16.10

USD

-0.28

- -

468.21MMarket Cap

Income Statement (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Sales/Revenue/Turnover	- -	- -
+ Sales & Services Revenue	- -	- -
- Cost of Revenue	- -	- -
+ Cost of Goods & Services	- -	- -
Gross Profit	- -	- -
+ Other Operating Income	- -	- -
- Operating Expenses	36	64
+ Selling, General & Admin	5	8
+ Research & Development	32	56
+ Other Operating Expense	- -	- -
Operating Income (Loss)	-36	-64
- Non-Operating (Income) Loss	-6	-3
+ Interest Expense, Net	-6	-3
+ Interest Expense	- -	- -
- Interest Income	6	3
+ Other Non-Op (Income) Loss	- -	- -
Pretax Income	-31	-61
- Income Tax Expense (Benefit)	- -	- -
- (Income) Loss from Affiliates	- -	- -
Income (Loss) from Cont Ops	-31	-61
- Net Extraordinary Losses (Gains)	- -	- -
+ Discontinued Operations	- -	- -
+ Extraord. & Accounting Changes	- -	- -
Income (Loss) Incl. MI	-31	-61
- Minority Interest	- -	- -
Net Income, GAAP	-31	-61
- Preferred Dividends	- -	- -
- Other Adjustments	- -	- -
Net Income Avail to Common, GAAP	-31	-61
EBIT	-36	-64
EBITDA	-36	-64
EBITDA Margin (%)	- -	- -
EBITA	-36	-64
Gross Margin (%)	- -	- -
Operating Margin (%)	- -	- -
Profit Margin (%)	- -	- -
Sales per Employee	- -	- -
Dividend per Share	- -	- -
Depreciation Expense	- -	- -
Basic Weighted Avg Shares	29	29
Basic EPS, GAAP	-1.06	-2.08
Basic EPS from Cont Ops	-1.06	-2.08
Diluted Weighted Avg Shares	29	29
Diluted EPS, GAAP	-1.06	-2.08
Diluted EPS from Cont Ops	-1.06	-2.08

Balance Sheet (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Total Current Assets	104	139
+ Cash, Cash Equivalents & STI	100	137
+ Cash & Cash Equivalents	100	137
+ ST Investments	- -	- -
+ Accounts & Notes Receiv	- -	- -
+ Accounts Receivable, Net	- -	- -
+ Notes Receivable, Net	- -	- -
+ Loans Receivable, Net	- -	- -
+ Other Receivable, Net	- -	- -
+ Inventories	- -	- -
+ Raw Materials	- -	- -
+ Work In Process	- -	- -
+ Finished Goods	- -	- -
+ Inventory Adjustments	- -	- -
+ Other Inventory	- -	- -
+ Other ST Assets	4	2
+ Misc ST Assets	- -	- -
+ Prepaid Expenses	- -	- -
+ ST Derivative & Hedging Assets	- -	- -
+ ST Assets Held-for-Sale	- -	- -
+ ST Deferred Tax Assets	- -	- -
Total Noncurrent Assets	3	24
+ Property, Plant & Equip, Net	1	22
+ Property, Plant & Equip	2	23
- Accumulated Depreciation	1	1
+ LT Investments & Receivables	- -	- -
+ LT Investments	- -	- -
+ LT Receivables	- -	- -
+ Other LT Assets	1	3
+ Total Intangible Assets	- -	- -
+ Goodwill	- -	- -
+ Other Intangible Assets	- -	- -
+ LT Deferred Tax Assets	- -	- -
+ LT Derivative & Hedging Assets	- -	- -
+ Misc LT Assets	1	2
Total Assets	107	163
+ Payables & Accruals	6	15
+ Accounts Payable	1	2
+ Accrued Taxes	- -	- -
+ Interest & Dividends Payable	- -	- -
+ Other Payables & Accruals	5	13
+ ST Debt	1	- -
+ ST Borrowings	- -	- -
+ ST Finance Leases	1	- -
+ Other ST Liabilities	- -	- -
+ Deferred Revenue	- -	- -
+ Derivatives & Hedging	- -	- -
+ Deferred Tax Liabilities	- -	- -
+ Misc ST Liabilities	- -	- -
Total Current Liabilities	7	15
+ LT Debt	- -	22
+ LT Borrowings	- -	- -
+ LT Finance Leases	- -	22
+ Other LT Liabilities	173	257
+ Accrued Liabilities	- -	- -
+ Pension Liabilities	- -	- -
+ Deferred Revenue	- -	- -
+ Deferred Tax Liabilities	- -	- -
+ Derivatives & Hedging	- -	- -
+ Misc LT Liabilities	173	257
Total Noncurrent Liabilities	173	279
Total Liabilities	180	295
+ Preferred Equity and Hybrid Capital	- -	- -
+ Share Capital & APIC	2	3
+ Common Stock	- -	- -
+ Additional Paid in Capital	2	3
- Treasury Stock	- -	- -
+ Retained Earnings	-74	-135
+ Other Equity	- -	- -
Equity Before Minority Interest	-73	-132
+ Minority/Non Controlling Interest	- -	- -
Total Equity	-73	-132
Total Liabilities & Equity	107	163
Shares Outstanding	29	29
Number of Employees	- -	- -
Capital Leases - Total	1	22
Net Debt	-100	-137
Net Debt to Equity	137.41	103.76
Tangible Common Equity Ratio	-68.4	-80.93
Current Ratio	15.38	8.97
Cash Conversion Cycle	- -	- -

Cash Flow Statement (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

+ Net Income	-31	-61
+ Depreciation & Amortization	- -	- -
+ Non-Cash Items	1	2
+ Stock-Based Compensation	1	1
+ Deferred Income Taxes	- -	- -
+ Asset Impairment Charge	- -	- -
+ Other Non-Cash Adj	1	1
+ Chg in Non-Cash Work Cap	-2	11
+ (Inc) Dec in Accts Receiv	- -	- -
+ (Inc) Dec in Inventories	- -	- -
+ (Inc) Dec in Prepaid Assets	-5	2
+ Inc (Dec) in Accts Payable	2	9
+ Inc (Dec) in Other	- -	- -
+ Net Cash From Disc Ops	- -	- -
Cash from Operating Activities	-31	-47
+ Change in Fixed & Intang	- -	- -
+ Disp in Fixed & Intang	- -	- -
+ Disp of Fixed Prod Assets	- -	- -
+ Disp of Intangible Assets	- -	- -
+ Acq of Fixed & Intang	- -	-1
+ Acq of Fixed Prod Assets	- -	-1
+ Acq of Intangible Assets	- -	- -
+ Cash (Repurchase) of Equity	- -	- -
+ Increase in Capital Stock	- -	- -
+ Decrease in Capital Stock	- -	- -
+ Net Change in LT Investment	- -	- -
+ Dec in LT Investment	- -	- -
+ Inc in LT Investment	- -	- -
+ Net Cash From Acq & Div	- -	- -
+ Cash from Divestitures	- -	- -
+ Cash for Acq of Subs	- -	- -
+ Cash for JVs	- -	- -
+ Other Investing Activities	- -	- -
+ Net Cash From Disc Ops	- -	- -
Cash from Investing Activities	- -	-1
+ Dividends Paid	- -	- -
+ Net Cash From Debt	- -	- -
+ Cash From Debt	- -	- -
+ Repayments of Debt	- -	- -
+ Other Financing Activities	18	85
+ Net Cash From Disc Ops	- -	- -
Cash from Financing Activities	18	85
Effect of Foreign Exchange Rates	- -	- -
Net Changes in Cash	-14	37
EBITDA	-36	-64
EBITDA Margin (%)	- -	- -
Free Cash Flow	-32	-48
Net Cash Paid for Acquisitions	- -	- -
Free Cash Flow to Firm	- -	- -
Free Cash Flow to Equity	- -	-48
Free Cash Flow per Basic Share	-1.08	-1.65
Price/Free Cash Flow	- -	- -
Cash Flow to Net Income	1.02	0.77
Capital Expenditures	- -	-1